Standardized efficacy and safety evaluation of fulranumab for osteoarthritis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Fulranumab effectively reduces pain and improves quality of life in osteoarthritis patients. This meta-analysis supports fulranumab as a viable therapeutic option for managing osteoarthritis symptoms.
Area Of Science
- Rheumatology
- Pharmacology
- Clinical Trials
Background
- Osteoarthritis (OA) is a prevalent degenerative joint disease causing significant pain and reduced quality of life.
- Current OA treatments aim to manage symptoms and slow disease progression, but novel therapeutic strategies are continuously sought.
- Fulranumab, a therapeutic agent, has emerged as a potential intervention for OA management.
Purpose Of The Study
- To evaluate the efficacy of fulranumab intervention in patients diagnosed with osteoarthritis.
- To provide an evidence-based clinical guide for utilizing fulranumab in OA patient care.
- To synthesize findings from randomized controlled trials (RCTs) assessing fulranumab's impact on OA.
Main Methods
- A systematic literature search was conducted across PubMed, Embase, Web of Science, and the Cochrane Library.
- Data from 8 randomized controlled trials involving 1927 osteoarthritis patients were included in the meta-analysis.
- RevMan 5.4 software was employed for the meta-analysis to assess treatment effects.
Main Results
- Fulranumab intervention demonstrated significant improvements in pain reduction compared to control groups.
- Specific findings include notable reductions in WOMAC pain scores and BPI-SF pain intensity and interference scores.
- The intervention also showed positive impacts on patient global assessment and overall quality of life.
Conclusions
- Fulranumab represents an effective therapeutic alternative for osteoarthritis, particularly when considered alongside nerve growth factor (NGF) therapies.
- Patients with osteoarthritis may experience substantial enhancements in clinical symptoms, pain scores, and quality of life with fulranumab treatment.
- Fulranumab presents a promising therapeutic avenue for improving outcomes in osteoarthritis management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...